Topsoe’s new facility in Denmark will manufacture electrolyzers in order to produce green hydrogen. The factory is expected to have an initial 500 MW manufacturing capacity and will be operational by 2025.

Sasol and Topsoe have entered into a single license agreement for Arcadia’s Vordingborg efuels plant. The first commercial efuels plant in Denmark is expected to produce approx. 100 million litres per year of efuels.

Under a joint development agreement between LG Chem and Gevo, both the firms will work together to develop a technology that produces 100 % bio-propylene from renewable sources of carbohydrates such as corn.

Under a strategic partnership between Origin Materials and Indorama Ventures, both the firms will work towards accelerating the mass production of bio-based materials. For this, the companies will also explore the option of converting an Indorama Ventures’ U.S. facility into a bio-based materials plant in order to develop and commercialize low-carbon bio-based materials.

Jindan has entered into an agreement with Sulzer under which the company will utilize Sulzer’s licensed PLA technology at its new manufacturing plant to produce up to 75’000 tonnes of polylactic acid annually.

Under a long-term agreement, Linde will develop a nine-megawatt alkaline electrolyzer plant on Jurong Island, Singapore in order to produce and supply green hydrogen to Evonik in Singapore. The plant is expected to be the largest electrolyzer ever installed in the country.

Asahi Kasei, Microwave Chemical have plans to conduct a joint demonstration project for chemical recycling of Polyamide 66 using the microwave technology. With this project, the firms aim to depolymerize PA66 and directly obtain the HMD and ADA monomers at high yields and a low energy consumption.

Under a commercial cooperation agreement signed between Lummus Technology and Texplore, Lummus Technology will license Texplore’s Excene HDPE technology. Lummus will also provide engineering design for plant construction, services for plant commissioning and start up while Texplore will provide their EL-Cat catalyst supply.

The move is claimed to be one of the world’s largest ever PEM electrolyzer deals wherein Ohmium has been selected by NTPC to deploy its electrolyzers in up to 400 MW of projects across a wide range of industrial and commercial applications.

Bristol Myers Squibb has plans to strengthen and expand its cell therapy manufacturing network by adding a new U.S. manufacturing facility for producing in-house viral vectors. The move follows a partnership agreement with Novartis.